9004 J. Am. Chem. Soc., Vol. 120, No. 35, 1998
LeCloux et al.
1735, 1696, 1602, 1404, 1463, 1358, 1334, 1218, 1195, 1087, 1039,
958, 835, 760, 626 cm-1; UV-vis (CH2Cl2) (λmax, nm (ꢀ, M-1 cm-1))
364 (580). Anal. Calcd for C42H48N4O8Fe: C, 63.64; H, 6.10; N, 7.07.
Found: C, 61.33; H, 6.26; N, 6.60. Since an X-ray structure
determination revealed 4 to be the desired material, the disagreement
with the expected carbon analysis was not pursued further.
[Fe(BXDK)(py)2] (5). This compound was prepared as a light
yellow powder from Tl2(BXDK) (2.33 g, 1.61 mmol), pyridine (560
µL, 6.92 mmol), and FeBr2 (354 mg, 1.61 mmol) by a procedure
analogous to that used to obtain 4 (1.55 g, 77%). The crude material
was used for all subsequent reactions. Recrystallization from CH2Cl2/
Et2O provided 5 as opaque yellow needles. IR (KBr) 3062, 3027, 2921,
2857, 1734, 1693, 1603, 1495, 1446, 1352, 1191, 1040, 935, 761, 700,
593, 526 cm-1; UV-vis (CH2Cl2) (λmax, nm (ꢀ, M-1 cm-1)) 361 (690).
Anal. Calcd for C78H72N4O8Fe: C, 74.99; H, 5.81; N, 4.48. Found:
C, 74.45; H, 5.80; N, 4.34.
[Fe2(µ-BXDK)(µ-O2Ct-Bu)(O2Ct-Bu)(py)2] (6). To a stirred solu-
tion of TlO2Ct-Bu (147 mg, 0.480 mmol) and pyridine (116 µL, 1.44
mmol) in THF (3 mL) was added FeBr2 (53 mg, 0.24 mmol) in THF
(1 mL). After 10 min this mixture was added in one portion to a stirred
solution of 5 (300 mg, 0.240 mmol) in CH2Cl2 (3 mL). The resulting
mixture was allowed to stir for 0.5 h, after which time the precipitated
TlBr was removed by filtration through Celite, and the volatile
components were removed in vacuo. Recrystallization from CH2Cl2/
Et2O afforded 6 as yellow blocks (265 mg, 73%) which allowed the
compound to be characterized by X-ray crystallography. IR (KBr)
3062, 3028, 2959, 2923, 2863, 1734, 1693, 1602, 1541, 1486, 1407,
1365, 1221, 1189, 1042, 937, 763, 701, 608, 528 cm-1; UV-vis (CH2-
Cl2) (λmax, nm (ꢀ, M-1 cm-1)) 355 (920). Anal. Calcd for C88.5H91N4O12-
Fe2Cl (6‚0.5CH2Cl2): C, 68.59; H, 5.92; N, 3.61. Found: C, 68.45;
H, 6.06; N, 3.48. One lattice CH2Cl2 molecule identified by X-ray
crystallography was apparently not removed completely by pumping
on the sample in vacuo for 1 d. When this procedure was repeated
with heating, the sample decomposed.
[Fe2(µ-XDK)(µ-O2CPhCy)(O2CPhCy)(py)2] (7). This compound
was prepared from Tl(O2CPhCy) (308 mg, 0.757 mmol), pyridine (184
µL, 2.27 mmol), FeBr2 (83 mg, 0.378 mmol), and 4 (300 mg, 0.378
mmol), as described for 6. Recrystallization from benzene/pentane
afforded 7 as pale yellow blocks which were characterized by X-ray
crystallography (291 mg, 61%). IR (KBr) 3063, 2960, 2928, 2862,
1737, 1699, 1614, 1448, 1405, 1355, 1221, 1187, 1069, 957, 851, 760,
698, 637 cm-1; UV-vis (CH2Cl2) (λmax, nm (ꢀ, M-1 cm-1)) 354 (840).
Anal. Calcd for C68H78N4O12Fe2: C, 65.08; H, 6.26; N, 4.46. Found:
C, 64.09; H, 6.63; N, 4.08.
[Fe2(µ-BXDK)(µ-O2CCH2t-Bu)(O2CCH2t-Bu)(py)2] (11). This
compound was prepared from TlO2CCH2t-Bu (77 mg, 0.24 mmol),
pyridine (60 µL, 0.72 mmol), FeBr2 (26 mg, 0.12 mmol), and 5 (150
mg, 0.120 mmol) as described for 6. Recrystallization from THF/
pentane provided 11 as yellow blocks (130 mg, 71%). IR (KBr) 3062,
3028, 2952, 2866, 1733, 1693, 1603, 1548, 1447, 1364, 1190, 1041,
936, 744, 701, 528 cm-1; UV-vis (CH2Cl2) (λmax, nm (ꢀ, M-1 cm-1))
358 (960). Anal. Calcd for C90H94N4O12Fe2: C, 70.40; H, 6.17; N,
3.65. Found: C, 70.20; H, 6.60; N, 3.26.
[Fe2(µ-BXDK)(µ-O2CPh)(O2CPh)(py)2] (12). This compound was
prepared from TlO2CPh (78 mg, 0.24 mmol), pyridine (60 µL, 0.72
mmol), FeBr2 (26 mg, 0.12 mmol), and 5 (150 mg, 0.120 mmol) as
described for 6. Recrystallization from THF/CH2Cl2/pentane provided
12 as yellow blocks (132 mg, 71%) which appeared suitable for X-ray
crystallography. IR (KBr) 3061, 3028, 2952, 2920, 2865, 1733, 1694,
1604, 1543, 1495, 1447, 1364, 1189, 1069, 1042, 937, 853, 762, 720,
701, 588, 528 cm-1; UV-vis (CH2Cl2) (λmax, nm (ꢀ, M-1 cm-1)) 351
(1400). Anal. Calcd for C93H84N4O12Fe2Cl2 (12‚CH2Cl2): C, 68.43;
H, 5.19; N, 3.43. Found: C, 68.84; H, 5.21; N, 3.13.
[Fe2(µ-BXDK)(µ-O2CPhCy)(O2CPhCy)(py)2] (13). This com-
pound was prepared from TlO2CPhCy (391 mg, 0.960 mmol), pyridine
(233 µL, 2.88 mmol), FeBr2 (106 mg, 0.480 mmol), and 5 (600 mg,
0.480 mmol) as described for 6. Recrystallization from CH2Cl2/THF/
pentane provided 13 as yellow blocks (623 mg, 76%) which appeared
suitable for X-ray crystallography. IR (KBr) 3061, 3028, 2920, 2856,
1735, 1696, 1605, 1494, 1452, 1398, 1366, 1191, 1073, 1042, 864,
762, 699, 526 cm-1; UV-vis (CH2Cl2) (λmax, nm (ꢀ, M-1 cm-1)) 354
(940). Anal. Calcd for C104H102N4O12Fe2: C, 72.98; H, 6.01; N, 3.27.
Found: C, 72.73; H, 6.09; N, 3.02.
[Fe2(µ-BXDK)(µ-O2CAr)(O2CAr)(py)2] (14). This compound was
prepared from TlO2CAr (108 mg, 0.240 mmol), pyridine (60 µL, 0.72
mmol), FeBr2 (26 mg, 0.12 mmol), and 5 (150 mg, 0.120 mmol) as
described for 6. Recrystallization from benzene/pentane provided 14
as yellow blocks (144 mg, 67%). IR (KBr) 3068, 3028, 2960, 2928,
2868, 1733, 1693, 1605, 1462, 1406, 1362, 1190, 1070, 937, 762, 701,
730, 528 cm-1; UV-vis (CH2Cl2) (λmax, nm (ꢀ, M-1 cm-1)) 352 (870).
Anal. Calcd for C110H118N4O12Fe2: C, 73.41; H, 6.61; N, 3.11.
Found: C, 72.96; H, 7.10; N, 3.03.
[Fe2(µ-XDK)(µ-O2CPhCy)(O2CPhCy)(Me-Im)2] (15). To a stirred
suspension of Tl2(XDK) (420 mg, 0.425 mmol) and Me-Im (71 µL,
0.89 mmol) in THF (5 mL) was added FeBr2 (187 mg, 0.851 mmol) in
THF (2 mL) followed by TlO2CPhCy (347 mg, 0.851 mmol) in THF
(2 mL). After 12 h the mixture was allowed to settle and the majority
of the precipitated TlBr was removed by filtration through Celite. The
resulting cloudy filtrate was evaporated to dryness and taken up in
benzene. Filtration through Celite afforded a clear filtrate. The Celite/
TlBr filter cakes were extracted twice with THF (5 mL) to obtain
additional product. The combined filtrate was evaporated to dryness
to yield a white residue. This material was suspended in pentane (10
mL), and the resulting white powder was isolated by filtration.
Recrystallization from THF/pentane afforded 15 as colorless needles
(386 mg, 72%). IR (KBr) 2959, 2929, 2859, 1734, 1695, 1609, 1535,
[Fe2(µ-XDK)(µ-O2CAr)(O2CAr)(py)2], O2CAr ) 2,4,6-Triiso-
propylbenzoate (8). This compound was prepared from TlO2CAr (342
mg, 0.757 mmol), pyridine (184 µL, 2.27 mmol), FeBr2 (83 mg, 0.378
mmol), and 4 (300 mg, 0.378 mmol) as described for 6. Recrystalli-
zation from THF/pentane provided 8 as yellow blocks (285 mg, 56%).
IR (KBr) 2960, 2870, 1736, 1699, 1611, 1536, 1464, 1412, 1357, 1220,
1192, 1069, 958, 841, 760, 698, 511 cm-1; UV-vis (CH2Cl2) (λmax
,
nm (ꢀ, M-1 cm-1)) 353 (790). Anal. Calcd for C74H94N4O12Fe2: C,
66.17; H, 7.05; N, 4.17. Found: C, 66.17; H, 7.01; N, 3.80.
1462, 1405, 1357, 1228, 1192, 1087, 958, 852, 762, 697, 628 cm-1
.
Anal. Calcd for C66H80N6O12Fe2: C, 62.86; H, 6.39; N, 6.66. Found:
C, 62.66; H, 6.79; N, 6.00.
[Fe2(µ-XDK)(µ-O2CAr)(O2CAr)(3-Fpy)2] (9). This compound was
prepared from TlO2CAr (342 mg, 0.757 mmol), 3-fluoropyridine (157
µL, 1.82 mmol), FeBr2 (83 mg, 0.378 mmol), and 4 (300 mg, 0.378
mmol) as described for 6. Recrystallization from THF/pentane provided
9 as yellow blocks (246 mg, 48%). IR (KBr) 2962, 2931, 2870, 1735,
[Fe2(µ-PXDK)(µ-O2CPhCy)(O2CPhCy)(Bu-Im)2] (16). This com-
pound was prepared from Tl2(PXDK) (788 mg, 0.682 mmol), Bu-Im
(184 µL, 1.40 mmol), FeBr2 (300 mg, 1.36 mmol), and TlO2CPhCy
(556 mg, 1.36 mmol) as described for 15. Recrystallization from Et2O/
pentane at -30 °C provided 16 as colorless needles (737 mg, 71%).
Recrystallization from a highly dilute pentane solution over several
days at room temperature yielded colorless blocks which allowed the
compound to be characterized by X-ray crystallography. IR (KBr)
3127, 2959, 2872, 1734, 1693, 1612, 1526, 1456, 1371, 1246, 1187,
1109, 948, 828, 763, 697, 660, 574 cm-1. Anal. Calcd for C84H116N6O12-
Fe2: C, 66.66; H, 7.72; N, 5.55. Found: C, 65.13; H, 7.81; N, 5.14.
Collection and Reduction of X-ray Data. Data were collected on
a Siemens CCD X-ray diffraction system controlled by a Pentium-
based PC running the SMART software package.31 All crystals were
1697, 1608, 1463, 1409, 1359, 1233, 1197, 1101, 959, 761, 537 cm-1
;
UV-vis (CH2Cl2) (λmax, nm (ꢀ, M-1 cm-1)) 361 (790). Anal. Calcd
for C74H92N4O12Fe2F2: C, 64.44; H, 6.72; N, 4.06. Found: C, 63.95;
H, 6.96; N, 3.53.
[Fe2(µ-BXDK)(µ-O2Ci-Pr)(O2Ci-Pr)(py)2] (10). This compound
was prepared from TlO2Ci-Pr (70 mg, 0.24 mmol), pyridine (60 µL,
0.72 mmol), FeBr2 (26 mg, 0.12 mmol), and 5 (150 mg, 0.120 mmol)
as described for 6. Recrystallization from THF/pentane provided 10
as yellow needles (135 mg, 76%). IR (KBr) 3062, 3028, 2965, 2923,
2869, 1733, 1693, 1602, 1546, 1495, 1446, 1364, 1190, 1034, 850,
763, 701, 528 cm-1; UV-vis (CH2Cl2) (λmax, nm (ꢀ, M-1 cm-1)) 357
(920). Anal. Calcd for C86H86N4O12Fe2: C, 69.82; H, 5.86; N, 3.79.
Found: C, 69.34; H, 6.05; N, 3.50.
(31) SMART; Version 4.0, Siemens Industrial Automation, Inc.: Madison,
WI, 1995.